Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,650
Total Claims
$939K
Drug Cost
514
Beneficiaries
$1,828
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+54%
Opioid rate vs peers
5.8% vs 3.8% avg
+56%
Cost per patient vs peers
$1,828 vs $1,174 avg
+33%
Brand preference vs peers
11.8% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.8%
Opioid Rate
620
Opioid Claims
$13K
Opioid Cost
2.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,243 claims · $739K
Generic: 9,305 claims · $193K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 136 | $100K |
| Semaglutide | 61 | $85K |
| Fluticasone/Umeclidin/Vilanter | 102 | $83K |
| Empagliflozin | 36 | $37K |
| Linaclotide | 40 | $36K |
| Cariprazine Hcl | 25 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $29K |
| Mirabegron | 35 | $26K |
| Sitagliptin Phosphate | 21 | $21K |
| Rivaroxaban | 26 | $20K |
| Umeclidinium Brm/Vilanterol Tr | 30 | $19K |
| Fluticasone/Vilanterol | 34 | $15K |
| Budesonide/Formoterol Fumarate | 35 | $14K |
| Insulin Degludec | 14 | $9,363 |
| Gabapentin | 406 | $8,734 |
Prescribing Profile
Patient Profile
71
Avg Age
69%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About